A phase IIb trial of ZPL 3893787 (ZPL-389) in patients with atopic dermatitis

Trial Profile

A phase IIb trial of ZPL 3893787 (ZPL-389) in patients with atopic dermatitis

Planning
Phase of Trial: Phase II

Latest Information Update: 24 May 2016

At a glance

  • Drugs ZPL 3893787 (Primary)
  • Indications Atopic dermatitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 May 2016 New trial record
    • 16 May 2016 The company is planning to begin this trial later this year, according to a Ziarco Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top